drugset / Trial / NCT00794599

Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03182)

NCT00794599

Phase 4 Completed 118 enrolled Organon and Co
RandomizedCrossoverOpen-labelOther

Summary

This was a crossover study designed to see if patients with allergy symptoms preferred Clarinex® or Zyrtec®. Patients were randomized to take 7 days of Clarinex or Zyrtec treatment, followed by a 5 to 28-day washout period (days when no drug is given), followed by 7 days of the opposite treatment. At the end of each 7-day treatment, patients were asked questions to determine which drug, Clarinex or Zyrtec, the patient prefers more.

Timeline

Start
2002-12
Primary completion
2003-08
Completion
2003-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Cetirizine Other / unclassified 10 mg Oral
Subject Desloratadine Small molecule 5 mg Oral